Drugs / Autologous dendritic cells pulsed with antigen
Autologous dendritic cells pulsed with antigen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04199559 | Dec 2019 → Jan 2021 | non-small cell lung carcinoma | Henan Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous dendritic cells pulsed with antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04199559 ↗ |
| Modality | Cell therapy | “Each dose contains of 10 million activated autologous DCs.” NCT04199559 ↗ |